Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Details)

v3.21.2
Stock Based Compensation (Details)
 9 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Number of shares  
Number of shares, Beginning balance 16,218,326
Number of shares, Grants 0
Number of shares, Exercises (150,000)
Number of shares, Expiration 0
Number of shares, Ending balance 16,068,326
Options exercisable, Ending balance 16,068,326
Weighted Average Exercise Price  
Weighted Average Exercise Price, Beginning balance | $ / shares $ 0.50
Weighted Average Exercise Price, Exercises | $ / shares 0.75
Weighted Average Exercise Price, Ending balance | $ / shares 0.49
Options exercisable, Ending balance | $ / shares $ 0.49
Weighted Average Remaining Contractual Life (years)  
Weighted Average Remaining Contractual Life (years), Beginning balance 3 years 6 months 25 days
Weighted Average Remaining Contractual Life (years), Ending balance 2 years 10 months 13 days
Options exercisable, Ending balance 2 years 10 months 13 days
Aggregate Intrinsic Value  
Aggregate Intrinsic Value, Beginning balance | $ $ 3,588,631
Aggregate Intrinsic Value, Ending balance | $ 3,701,564
Options exercisable, Ending balance, Intrinsic value | $ $ 3,701,564